EU Aims for Tougher Scrutiny of Silicon Valley Data-Heavy Deals

Advertisement
By Gaspard Sebag, Bloomberg | Updated: 7 October 2016 18:14 IST

The European Union may include purchase prices in the criteria used to trigger its antitrust probes, aiming to catch more data-heavy transactions in serious merger reviews in another warning shot to Silicon Valley.

The European Commission said Friday the EU's revenue-based rules mean some deals can currently avoid scrutiny when the target company doesn't have significant sales even if it "already plays a competitive role, holds commercially valuable data, or has a considerable market potential for other reasons."

EU antitrust chief Margrethe Vestager, who took office at the end of 2014, has signaled a willingness to delve more into how merging companies leverage the trove of data at their disposal. Data was one of the key considerations in the review of Facebook Inc.'s takeover of messaging service WhatsApp Inc. While the EU cleared it in October 2014, Vestager said last month officials were now "asking some follow-up questions" about privacy-policy changes.

Advertisement

Vestager signalled in June that Microsoft Corp.'s acquisition of professional social network LinkedIn Corp. is another deal where any EU probe would likely focus on its potential to leverage vast amounts of user data.

Advertisement

"Players in the digital economy may have considerable actual or potential market impact that may be reflected in high acquisition values, although they may not yet generate any or only little turnover," the EU said Friday as it sought feedback on possible changes. "It has been suggested to complement the existing turnover-based jurisdictional thresholds of the EU merger regulation by additional notification requirements based on alternative criteria, such as the transaction value."

The EU considers the possible legal gap may also affect the pharmaceutical industry.

Advertisement

"There have been indeed a number of highly valued acquisitions, by major pharmaceutical companies, of small biotechnology companies, which predominantly research and develop new treatments that may have high commercial potential, and do not yet generate any or only little turnover," the commission said.

© 2016 Bloomberg L.P.

 

Catch the latest from the Consumer Electronics Show on Gadgets 360, at our CES 2026 hub.

Further reading: EU, Facebook, WhatsApp, Margrethe Vestager
Advertisement

Related Stories

Popular Mobile Brands
  1. These Smartphones Will Be Discounted During Flipkart Republic Day Sale
  2. iPhone 17 Pro, iPhone Air Will Go Sale at These Prices During Amazon's Sale
  3. Space Forge Tests World's First Commercial Semiconductor Factory in Space
  4. Amazon Great Republic Day Sale 2026: iQOO Smartphone Deals Revealed
  1. ISRO’s PSLV Suffers Second Failure as Third-Stage Glitch Sends Rocket Off Course
  2. NASA Confirms First Medical Evacuation in ISS’s 25-Year History
  3. Space Forge Tests World’s First Commercial Semiconductor Factory in Space
  4. 83rd Golden Globe Awards Full List of Winners: Hamnet, The Pitt, Adolescence, and More
  5. Kirkkan OTT Release Date: When and Where to Watch This Gripping Crime Investigation Drama Online?
  6. Mana Shankara Vara Prasad Garu OTT Release Date Reportedly Leaked Online
  7. Forza Horizon 5 Is Said to Have Sold Over 5 Million Copies on PS5
  8. Realme Neo 8 Display Details Teased; TENAA Listing Reveals Key Specifications
  9. iPhone 17 Pro, iPhone 17 Pro Max, iPhone Air Discounts Revealed Ahead of Amazon Great Republic Day Sale 2026
  10. Google’s AI Overviews Giving Incorrect Medical Advice as OpenAI, Anthropic Push for Healthcare: Report
Gadgets 360 is available in
Download Our Apps
Available in Hindi
© Copyright Red Pixels Ventures Limited 2026. All rights reserved.